healthcare
Fortis healthcare raises $100m from IFC
Indian hospital and diagnostics group Fortis Healthcare is to issue 28.6 million shares to the International Finance Corporation (IFC) for a total of $45 million. Another $55 million will come through a private placement of foreign currency convertible...
IDFC, Capital International exit India's Manipal Group via share buyback
India’s Manipal Group has raised around $260 million in debt to buy back IDFC PE and Capital International’s stake in Manipal Education and Medical Group International India (MEMG).
CITIC-backed consortium sweetens deal for China 3SBio take-private
A consortium backed by CITIC Private Equity has raised its offer for the Chinese biotechnology company 3SBio to around $370 million.
Somerset Indus invests in specialty hospital chain
Indian healthcare-focused PE firm Somerset Indus Capital Partners has invested in tertiary care hospital chain Cygnus Medicare. The investment will support the chain’s expansion across Haryana and the National Capital Region (NCR) surrounding Delhi.
Goldman, GIC invest $100m in China healthcare play iKang
Goldman Sachs and Government of Singapore Investment Corporation (GIC) have committed $100 million to Chinese private health management company iKang.
3SBio shareholder opposes CITIC PE-backed take-private
One of the largest shareholders of Chinese biotechnology firm 3SBio plans to oppose a take-private bid tabled by CEO Jing Lou and CITIC Private Equity that values the company at $340 million.
TPG completes take-private of China’s ShangPharma
TPG Capital has completed a management buyout of ShangPharma Corporation that values the Chinese pharmaceutical and biotech research outsourcing firm at $173 million. It is the sixth private equity-backed privatization of a US-listed Chinese company to...
Qiming, KPCB lead $21.3m Series C investment in Origene
Qiming Venture Partners and KPCB China have led $21.3 million of Series C funding in OriGene Technologies, a biotech company based in the US and China.
Quadria Capital buys India’s Milestone Religare
Quadria Capital, which is currently raising a healthcare fund focused on South Asia and Southeast Asia, has acquired Milestone Religare Investment Advisors. Milestone Capital, joint owner of the asset alongside Religare Enterprises, had been looking for...
CNEI invests in Chinese drug developer
China New Enterprise Investment (CNEI) has committed $21 million to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (FDZJ), a Hong Kong-listed developer of drugs and diagnostic products.
Siemens sets up RMB venture fund
The venture capital arm of Siemens Financial Services (SFS VC), has set up a dedicated renminbi-denominated investment vehicle. The size of the fund has not been disclosed
Temasek’s Vertex leads Series B round for Clearbridge BioMedics
Vertex Ventures, a VC unit of Temasek Holdings, has led a Series B round of financing for Singapore-based Clearbridge BioMedics worth S$9 million ($7.2 million). Other participants include existing investor BioVeda, Spring Seeds Capital, Biosensors International...
Life sciences VC investor Domain creates China partnership
US-based venture capital firm Domain Associates has teamed up with Chinese financial advisor Elite Consulting to support Western healthcare companies entering China. Several global VC investors and related service providers have been bulking up their...
Temasek commits $24m to Indian oncology chain
Temasek Holdings has invested INR1.3 billion ($24 million) in Indian cancer care hospital chain Healthcare Global Enterprises (HCG). The deal facilitates the exit of Evolvence India Life Sciences Fund, a vehicle managed by Invascent Capital.
Hony supports $505m take-private of Simcere Pharmaceutical
Hony Capital is backing a $505 million management buyout of Chinese drug developer Simcere Pharmaceutical Group. It takes the number of take-private deals involving US-listed Chinese companies to 13, according to AVCJ Research.
WestBridge renews commitment to Pathlabs
WestBridge Capital'S involvement with India's Dr. Lal Pathlabs goes back to 2005, when the private equity firm invested around $10 million through its debut vehicle, WestBridge Venture Fund I.
KPCB, IDG-Accel invest $10m in China's EntreMed
KPCB China and IDG-Accel China have agreed to invest $10.7 million in EntreMed, a clinical-stage pharma company that develops drugs in the US and China for global release.
Apax Partners continues Apollo Hospitals exit
Apax Partners has continued its exit of Apollo Hospitals, selling a 3.8% stake for INR4.4 billion ($83 million).
Archer-owned Australian Aged Care buys Lend Lease's care unit
Australian Aged Care Partners, an Archer Capital portfolio company, has agreed to buy property group Lend Lease's aged care unit for A$270 million ($276 million). The transaction is expected to be completed by the end of March 2013.
OrbiMed launches Asia healthcare fund
Healthcare-focused PE firm OrbiMed Advisors will launch its second Asian healthcare fund towards the end of 2013, with a target of $500 million.
WestBridge, TA commit $44m to India’s Dr Lal Pathlabs
WestBridge Capital and TA Associates have jointly invested $44 million in Dr Lal PathLabs, a diagnostics and pathology services firm headquartered in Gurgoan, India.
Helion provides Series A round for India’s Lifecell
Helion Venture Partners has committed INR350 million ($6.5 million) to a Series A round of funding for LifeCell International, India’s first and largest stem cell banking company. The capital will be used to expand LifeCell’s domestic presence and...
Apax makes partial exit from Apollo Hospitals
Apax Partners has exited part of its stake in India' s Apollo Hospital to Oppenheimer Funds for INR5.3 billion ($97 million).
Healthy holidays: PE and medical tourism
Asia’s medical tourism sector is growing rapidly as visitors flock east for cheap surgical procedures. How big is the opportunity for private equity and where can it be found?